Skip to main content
SpringerLink
Log in

Two Decades of Huntington Disease Testing: Patient’s Demographics and Reproductive Choices

  • Original Research
  • Published:
Journal of Genetic Counseling

Abstract

Predictive testing for Huntington disease (HD) has been available in the United States (US) since 1987, and the Indiana University Predictive Testing Program has been providing this testing since 1990. To date there has been no published description of those who present for such testing in the US. Here we describe demographics of 141 individuals and reproductive decision making of a subset of 16 of those individuals who underwent predictive HD testing between 1990 and 2010 at one site in the US. This study is a retrospective chart review of the “Personal History Questionnaire” participants completed prior to testing. As seen in other studies, most participants were female (64.5 %), in their mid-30s (mean = 34), and had at least one child prior to testing (54 %). Multiple demographic datum points are described, and the reproductive decision making of these at-risk individuals was analyzed using Fisher’s Exact Tests. Of those women who had children before learning of their risk to inherit HD, those who attended church more frequently, had three or more children total, or whose mother was affected with HD were more likely to be comfortable with their choice to have children. We conclude that these demographic factors influence the reproductive decision-making of individuals at risk for HD. Psychologists, clinical geneticists, and genetic counselors may be able to use this information to help counsel at-risk patients regarding current or past reproductive decision making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Alonso, M. E., Ochoa, A., Sosa, A. L., Rodriguez, Y., Chavez, M., Boll, C., et al. (2009). Presymptomatic diagnosis in Huntington’s disease: the Mexican experience. Genetic Testing and Molecular Biomarkers, 13, 717–720.

    Article  PubMed  CAS  Google Scholar 

  • Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Philippe, K., Demyttenaere, K., Dom, R., et al. (2007). The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. European Journal of Human Genetics, 15, 453–462.

    Article  PubMed  Google Scholar 

  • Dufrasne, S., Roy, M., Galvez, M., & Rosenblatt, D. S. (2011). Experience over fifteen years with a protocol for predictive testing for Huntington disease. Molecular Genetics and Metabolism, 102, 494–504.

    Article  PubMed  CAS  Google Scholar 

  • Evers-Kiebooms, G., Nys, K., Harper, P., Zoeteweij, M., Dürr, A., Jacopini, G., et al. (2002). Predictive DNA-testing for Huntington’s disease and reproductive decision making: a European collaborative study. European Journal of Human Genetics, 10, 167–176.

    Article  PubMed  Google Scholar 

  • Foroud, T., Gray, J., Ivashina, J., & Conneally, P. M. (1999). Differences in duration of Huntington’s disease based on age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 66, 52–56.

    Article  PubMed  CAS  Google Scholar 

  • Forrest Keenan, K., Miedzybrodzka, Z., van Teijlingen, E., McKee, L., & Simpson, S. A. (2007). Young people’s experiences of growing up in a family affected by Huntington’s disease. Clinical Genetics, 71, 120–129.

    Article  PubMed  CAS  Google Scholar 

  • Genetic Information Nondiscrimination Act of 2008. (2008). § 42 U.S.C. §1635

  • Harper, P. S. (1992). The epidemiology of Huntington’s disease. Human Genetics, 89, 365–376.

    Article  PubMed  CAS  Google Scholar 

  • Harper, P. S., Lim, C., & Craufurd, D. (2000). Ten years of presymptomatic testing for Huntington’s disease: the experience of the UK Huntington’s disease prediction consortium. Journal of Medical Genetics, 37, 567–571.

    Article  PubMed  CAS  Google Scholar 

  • Huntington, G. (1872). On chorea. In Yudofsky, S.C. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 109–112. (Reprinted from The medical and surgical reporter: A weekly journal, 26, 317–321).

  • Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983.

    Article  Google Scholar 

  • Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Decision-making about reproductive choices among individuals at-risk for Huntington’s disease. Journal of Genetic Counseling, 16, 347–362.

    Article  PubMed  Google Scholar 

  • Koenig, H. G. (2009). Research on religion, spirituality, and mental health: a review. Canadian Journal of Psychiatry, 54, 283–291.

    Google Scholar 

  • Laccone, F., Engel, U., Hollinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland. Neurology, 53, 801–806.

    Article  PubMed  CAS  Google Scholar 

  • Panas, M., Karadima, G., Vassos, E., Kalfakis, N., Kladi, A., Christodoulou, K., et al. (2011). Huntington’s disease in Greece: the experience of 14 years. Clinical Genetics, 80, 586–590.

    Article  PubMed  CAS  Google Scholar 

  • Puchalski, C. (2001). The role of spirituality in health care. Baylor University Medical Center Proceedings, 14, 352–357.

    PubMed  CAS  Google Scholar 

  • Quaid, K. A., Swenson, M. M., Sims, S. L., Harrison, J. M., Moskowitz, C., Stepanov, N., et al. (2010). What were you thinking?: individuals at risk for Huntington disease talk about having children. Journal of Genetic Counseling, 19, 606–617.

    Article  PubMed  Google Scholar 

  • Richards, F. H., & Rea, G. (2005). Reproductive decision making before and after predictive testing for Huntington’s disease: an Australian perspective. Clinical Genetics, 67, 404–411.

    Article  PubMed  CAS  Google Scholar 

  • Roos, R. A. C., Hermans, J., Vegter-van der Vlis, M., van Ommen, G. J. B., & Bruyn, G. W. (1993). Duration of illness in Huntington’s disease is not related to age at onset. Journal of Neurology, Neurosurgery, and Psychiatry, 56, 98–100.

    Article  PubMed  CAS  Google Scholar 

  • Rubinsztein, D. C., Leggo, J., Coles, R., Almqvist, E., Biancalana, V., Cassiman, J. J., et al. (1996). Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal individuals with 36–39 repeats. American Journal of Medical Genetics, 59, 16–22.

    CAS  Google Scholar 

  • Simpson, S. A., Besson, J., Alexander, D., Allan, K., & Johnston, A. W. (1992). One hundred requests for predictive testing for Huntington’s disease. Clinical Genetics, 41, 326–330.

    Article  PubMed  CAS  Google Scholar 

  • Sturrock, A., & Leavitt, B. R. (2010). The clinical and genetic features of Huntington disease. Journal of Geriatric Psychiatry and Neurology, 23, 243–259.

    Article  PubMed  Google Scholar 

  • Taylor, S. (2005). Gender differences in attitudes among those at risk for Huntington’s disease. Genetic Testing and Molecular Biomarkers, 9, 152–157.

    Google Scholar 

  • Trembath, M. K., Tassicker, R. J., Collins, V. R., Mansie, S., Sheffield, L. J., & Delatycki, M. B. (2006). Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genetics in Medicine, 8, 673–680.

    Article  PubMed  Google Scholar 

  • U.S. Census Bureau. (2000). Indiana Summary Tables. Retrieved 2012 from http://factfinder2.census.gov.

  • U.S. Census Bureau. (2010). American FactFinder Sheet: Indiana. Retrieved 2012 from http://factfinder.census.gov.

  • United States Huntington’s Disease Genetic Testing Group. (2003). Genetic testing for Huntington’s disease: Its relevance and implications (revised). United States of America: Huntington’s Disease Society of America.

    Google Scholar 

  • Vamos, M., Hambridge, J., Edwards, M., & Conaghan, J. (2007). The impact of Huntington’s disease on family life. Psychosomatics, 48, 400–404.

    Article  PubMed  Google Scholar 

  • Van der Meer, L., Timman, R., Trijsburg, W., Duisterhof, M., Erdman, R., Van Elderen, T., et al. (2006). Attachment in families with Huntington’s disease a paradigm in clinical genetics. Patient Education and Counseling, 63, 246–254.

    Article  PubMed  Google Scholar 

  • van der Steenstraten, I. M., Tibben, A., Roos, R. A. C., van de Kamp, J. J. P., & Niermeijer, M. F. (1994). Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. American Journal of Human Genetics, 55, 618–625.

    PubMed  Google Scholar 

  • Venuto, C. S., McGarry, M., Ma, Q., & Kieburtz, K. (2012). Pharmacologic approaches to the treatment of Huntington’s disease. Movement Disorders, 27, 31–41.

    Article  PubMed  CAS  Google Scholar 

  • Walker, F. O. (2007). Huntington’s disease. Seminars in Neurology, 27, 143–150.

    Article  PubMed  Google Scholar 

  • Williams, J. K., Erwin, C., Juhl, A., Mills, J., Brossman, B., & Paulsen, J. S. (2010). Personal factors associated with reported benefits of Huntington disease family history or genetic testing. Genetic Testing and Molecular Biomarkers, 14, 629–636.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the patients who presented for HD predictive testing for their time and effort to complete this survey, along with the HD community at large for their support of ongoing research.

Author information

Authors and Affiliations

  1. Breast Care, Community Physician Network, 8040 Clearvista Parkway, Suite 550, Indianapolis, IN, 46256, USA

    Rebekah C. Krukenberg

  2. Department of Medical and Molecular Genetics, Indiana University School of Medicine, 975 W. Walnut Street, IB130, Indianapolis, IN, 46202-5251, USA

    Daniel L. Koller, David D. Weaver, Jennifer N. Dickerson & Kimberly A. Quaid

Authors
  1. Rebekah C. Krukenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel L. Koller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David D. Weaver
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jennifer N. Dickerson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kimberly A. Quaid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kimberly A. Quaid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krukenberg, R.C., Koller, D.L., Weaver, D.D. et al. Two Decades of Huntington Disease Testing: Patient’s Demographics and Reproductive Choices. J Genet Counsel 22, 643–653 (2013). https://doi.org/10.1007/s10897-013-9596-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-013-9596-0

Keywords

Search

Navigation